Treprostinil IV bulk supplier for pharma manufacturers

Treprostinil IV Suppliers & Bulk Manufacturers

Available Forms: SC or Intravenous (IV)

Available Strengths: 2 mg (0.1 mg/mL), 4 mg (0.2 mg/mL), 8 mg (0.4 mg/mL), 20 mg (1 mg/mL), 50 mg (2.5 mg/mL), 100 mg (5 mg/mL), 200 mg (10 mg/mL), or 400 mg (20 mg/mL)

Reference Brands: Remodulin(US & EU)

Category: Orphan Drugs

Treprostinil, administered via subcutaneous or intravenous infusion, is a prostacyclin analogue that dilates pulmonary blood vessels and inhibits platelet aggregation. It improves exercise capacity, reduces PAH symptoms, and enhances quality of life by lowering pulmonary arterial pressure and decreasing vascular resistance in patients with pulmonary arterial hypertension.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Treprostinil IV? List it or send an offer →

Product Description:

Treprostinil, marketed as Remodulin®, is approved in the US and EU for pulmonary arterial hypertension (PAH). Regulatory dossiers include comprehensive clinical data, manufacturing standards, and safety profiles submitted to FDA and EMA, supporting its approval for subcutaneous and intravenous use. The product is used for continuous infusion to improve exercise capacity and reduce symptoms. Dossiers demonstrate high-quality manufacturing and proven efficacy.

Treprostinil IV — third party manufacturing & bulk supply

Treprostinil IV is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Treprostinil IV is supplied as SC or Intravenous (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Treprostinil IV listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Treprostinil IV →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Treprostinil is used to treat pulmonary arterial hypertension (PAH). It helps improve exercise ability and reduces symptoms by relaxing and widening the blood vessels in the lungs, allowing blood to flow more easily.

Treprostinil is a synthetic analogue of prostacyclin, a naturally occurring substance in the body that helps dilate blood vessels and inhibit platelet aggregation.

Well-known trade names of treprostinil include Remodulin, Tyvaso, and Orenitram, depending on the dosage form and region.

The original brands were developed and marketed by United Therapeutics, and generic versions are now manufactured by several pharmaceutical companies in different countries.

The generic name of the medicine is treprostinil.

The main brand names are Remodulin, Tyvaso, and Orenitram.

Treprostinil products are manufactured in multiple countries including the United States, European countries, India, and other regions where approved pharmaceutical manufacturers produce the drug for global markets.